These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 29057041)

  • 1. Discovery of a Tetrahydrobenzisoxazole Series of γ-Secretase Modulators.
    Zhao Z; Pissarnitski DA; Huang X; Palani A; Zhu Z; Greenlee WJ; Hyde LA; Song L; Terracina G; Zhang L; Parker EM
    ACS Med Chem Lett; 2017 Oct; 8(10):1002-1006. PubMed ID: 29057041
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Discovery of Pyridone and Pyridazone Heterocycles as γ-Secretase Modulators.
    Huang X; Aslanian R; Zhou W; Zhu X; Qin J; Greenlee W; Zhu Z; Zhang L; Hyde L; Chu I; Cohen-Williams M; Palani A
    ACS Med Chem Lett; 2010 Jul; 1(4):184-7. PubMed ID: 24900193
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Discovery of a Potent Pyrazolopyridine Series of γ-Secretase Modulators.
    Qin J; Zhou W; Huang X; Dhondi P; Palani A; Aslanian R; Zhu Z; Greenlee W; Cohen-Williams M; Jones N; Hyde L; Zhang L
    ACS Med Chem Lett; 2011 Jun; 2(6):471-6. PubMed ID: 24900332
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of FRM-36143 as a new γ-secretase modulator for the potential treatment of familial Alzheimer's disease.
    Blain JF; Bursavich MG; Freeman EA; Hrdlicka LA; Hodgdon HE; Chen T; Costa DE; Harrison BA; Kapadnis S; Murphy DA; Nolan S; Tu Z; Tang C; Burnett DA; Patzke H; Koenig G
    Alzheimers Res Ther; 2016 Aug; 8(1):34. PubMed ID: 27572246
    [TBL] [Abstract][Full Text] [Related]  

  • 5. γ-Secretase modulator in Alzheimer's disease: shifting the end.
    Xia W; Wong ST; Hanlon E; Morin P
    J Alzheimers Dis; 2012; 31(4):685-96. PubMed ID: 22710916
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Design and synthesis of an aminopiperidine series of γ-secretase modulators.
    Kobayashi T; Iwama S; Fusano A; Kato Y; Ikeda A; Teranishi Y; Nishihara A; Tobe M
    Bioorg Med Chem Lett; 2014 Jan; 24(1):378-81. PubMed ID: 24269163
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis and SAR Studies of Fused Oxadiazines as γ-Secretase Modulators for Treatment of Alzheimer's Disease.
    Huang X; Zhou W; Liu X; Li H; Sun G; Mandal M; Vicarel M; Zhu X; Bennett C; McCraken T; Pissarnitski D; Zhao Z; Cole D; Gallo G; Zhu Z; Palani A; Aslanian R; Clader J; Czarniecki M; Greenlee W; Burnett D; Cohen-Williams M; Hyde L; Song L; Zhang L; Chu I; Buevich A
    ACS Med Chem Lett; 2012 Nov; 3(11):931-5. PubMed ID: 24900409
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Discovery of novel triazolobenzazepinones as γ-secretase modulators with central Aβ42 lowering in rodents and rhesus monkeys.
    Fischer C; Zultanski SL; Zhou H; Methot JL; Shah S; Hayashi I; Hughes BL; Moxham CM; Bays NW; Smotrov N; Hill AD; Pan BS; Wu Z; Moy LY; Tanga F; Kenific C; Cruz JC; Walker D; Bouthillette M; Nikov GN; Deshmukh SV; Jeliazkova-Mecheva VV; Diaz D; Michener MS; Cook JJ; Munoz B; Shearman MS
    Bioorg Med Chem Lett; 2015 Sep; 25(17):3488-94. PubMed ID: 26212776
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Discovery of 2-methylpyridine-based biaryl amides as γ-secretase modulators for the treatment of Alzheimer's disease.
    Chen JJ; Qian W; Biswas K; Yuan C; Amegadzie A; Liu Q; Nixey T; Zhu J; Ncube M; Rzasa RM; Chavez F; Chen N; DeMorin F; Rumfelt S; Tegley CM; Allen JR; Hitchcock S; Hungate R; Bartberger MD; Zalameda L; Liu Y; McCarter JD; Zhang J; Zhu L; Babu-Khan S; Luo Y; Bradley J; Wen PH; Reid DL; Koegler F; Dean C; Hickman D; Correll TL; Williamson T; Wood S
    Bioorg Med Chem Lett; 2013 Dec; 23(23):6447-54. PubMed ID: 24139583
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Discovery of tetrahydroindazoles as a novel class of potent and in vivo efficacious gamma secretase modulators.
    Gerlach K; Hobson S; Eickmeier C; Groß U; Braun C; Sieger P; Garneau M; Hoerer S; Heine N
    Bioorg Med Chem; 2018 Jul; 26(12):3227-3241. PubMed ID: 29735425
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel γ-secretase modulators: a review of patents from 2008 to 2010.
    Pettersson M; Kauffman GW; am Ende CW; Patel NC; Stiff C; Tran TP; Johnson DS
    Expert Opin Ther Pat; 2011 Feb; 21(2):205-26. PubMed ID: 21231889
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Discovery of indole-derived pyridopyrazine-1,6-dione γ-secretase modulators that target presenilin.
    Pettersson M; Johnson DS; Humphrey JM; Am Ende CW; Evrard E; Efremov I; Kauffman GW; Stepan AF; Stiff CM; Xie L; Bales KR; Hajos-Korcsok E; Murrey HE; Pustilnik LR; Steyn SJ; Wood KM; Verhoest PR
    Bioorg Med Chem Lett; 2015 Feb; 25(4):908-13. PubMed ID: 25582600
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Design and synthesis of a novel series of cyanoindole derivatives as potent γ-secretase modulators.
    Bischoff FP; Velter AI; Minne G; Pieters S; Berthelot D; De Cleyn M; Gijsen HJM; Macdonald G; Surkyn M; Van Brandt S; Van Roosbroeck Y; Zavattaro C; Mercken M; Austin N; Dhuyvetter D; Borghys H; Ahmad I; Samanta SK
    Bioorg Med Chem Lett; 2019 Jul; 29(14):1737-1745. PubMed ID: 31122869
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Discovery of novel 5,6,7,8-tetrahydro[1,2,4]triazolo[4,3-a]pyridine derivatives as γ-secretase modulators.
    Takai T; Hoashi Y; Tomata Y; Morimoto S; Nakamura M; Watanabe T; Igari T; Koike T
    Bioorg Med Chem Lett; 2015 Oct; 25(19):4245-9. PubMed ID: 26298496
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Discovery of novel 5,6,7,8-tetrahydro[1,2,4]triazolo[4,3-a]pyridine derivatives as γ-secretase modulators (Part 2).
    Takai T; Koike T; Nakamura M; Kajita Y; Yamashita T; Taya N; Tsukamoto T; Watanabe T; Murakami K; Igari T; Kamata M
    Bioorg Med Chem; 2016 Jul; 24(14):3192-206. PubMed ID: 27255179
    [TBL] [Abstract][Full Text] [Related]  

  • 16. APLP1 as a cerebrospinal fluid biomarker for γ-secretase modulator treatment.
    Sjödin S; Andersson KK; Mercken M; Zetterberg H; Borghys H; Blennow K; Portelius E
    Alzheimers Res Ther; 2015 Dec; 7(1):77. PubMed ID: 26689589
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Discovery of BIIB042, a Potent, Selective, and Orally Bioavailable γ-Secretase Modulator.
    Peng H; Talreja T; Xin Z; Cuervo JH; Kumaravel G; Humora MJ; Xu L; Rohde E; Gan L; Jung MY; Shackett MN; Chollate S; Dunah AW; Snodgrass-Belt PA; Arnold HM; Taveras AG; Rhodes KJ; Scannevin RH
    ACS Med Chem Lett; 2011 Oct; 2(10):786-91. PubMed ID: 24900267
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CTF1-51, a truncated carboxyl-terminal fragment of amyloid precursor protein, suppresses the effects of Aβ42-lowering γ-secretase modulators.
    Watahiki H; Yagishita S; Futai E; Ishiura S
    Neurosci Lett; 2012 Sep; 526(2):96-9. PubMed ID: 22940081
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Discovery of γ-secretase modulators with a novel activity profile by text-based virtual screening.
    Zettl H; Ness J; Hähnke V; Beher D; Jumpertz T; Saric A; Baumann K; Pietrzik CU; Bulic B; Schneider G; Weggen S
    ACS Chem Biol; 2012 Sep; 7(9):1488-95. PubMed ID: 22725102
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Iminoheterocycles as gamma-secretase modulators.
    Caldwell JP; Bennett CE; McCracken TM; Mazzola RD; Bara T; Buevich A; Burnett DA; Chu I; Cohen-Williams M; Josein H; Hyde L; Lee J; McKittrick B; Song L; Terracina G; Voigt J; Zhang L; Zhu Z
    Bioorg Med Chem Lett; 2010 Sep; 20(18):5380-4. PubMed ID: 20724152
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.